NDA 011870 · Salix Pharms
Diuril
Chlorothiazide · Oral · Thiazide Diuretic
DiscontinuedLast checked: Nov 20, 2026Latest source record: Jun 10, 2009 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations
First approved
1961
Oct 6, 1961
Approved uses
1
Original approval plus efficacy supplements
Registered trials
330
91 Phase 3, 10 recruiting
FAERS reports
1,263
1,011 serious, 199 with death reported
AI brief across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.
What it is approved for
From the label in effect Nov 1, 2021.
INDICATIONS AND USAGE DIURIL is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. DIURIL has also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. DIURIL is indicated in the management of hypertension either as the sole therapeutic agent or to enhance the effectiveness of other antihypertensive drugs in the more severe forms of hypertension. Use in Pregnancy - Routine use of diuretics during normal pregnancy is inappropriate and exposes mother and fetus to unnecessary hazard. Diuretics do not prevent development of toxemia of pregnancy and there is no satisfactory evidence that they are useful in the treatment of toxemia. Edema during pregnancy may arise from pathologic causes or from the physiologic and mechanical consequences of pregnancy. Thiazides are indicated in pregnancy when edema is due to pathologic causes, just as they are in the absence of pregnancy (see PRECAUTIONS, Pregnancy ). Dependent edema in pregnancy, resulting from restriction of venous return by the gravid uterus, is properly treated through elevation of the lower extremities and use of support stockings. Use of diuretics to lower intravascular volume in this instance is illogical and unnecessary. During normal pregnancy there is hypervolemia which is not harmful to the fetus or the mother in the absence of cardiovascular disease. However, it may be associated with edema, rarely generalized edema. If such edema causes discomfort, increased recumbency will often provide relief. Rarely this edema may cause extreme discomfort which is not relieved by rest. In these instances, a short course of diuretic therapy...
Approval history
Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.
- Oct 6, 1961 Original approval · Type 3 - New Dosage Form
1 products under this application
- DIURIL · CHLOROTHIAZIDE 250MG/5ML · SUSPENSION, ORAL · Discontinued
Clinical trials
Interventional ClinicalTrials.gov studies with "Chlorothiazide" as an intervention, any sponsor and status, largest first.
- INVEST: INternational VErapamil SR Trandolapril STudyPivotal-lookingCompleted
University of FloridaAcademic, hospital or other
NCT00133692 · 22,000 participants · Start Sep 1997
Drug: Verapamil SR/Trandolapril/Hydrochlorothiazide (HCTZ); Atenolol/HCTZ/Trandolapril · For: Hypertension; Coronary Artery Disease
Sites: Gainesville, Florida
- Diuretic Comparison ProjectPivotal-lookingCompleted
VA Office of Research and DevelopmentFederal agency
NCT02185417 · 20,723 participants · Start Jun 15, 2016 · Primary completion Oct 15, 2022
Drug: Hydrochlorothiazide (HCTZ); Chlorthalidone (CTD) · For: Hypertension
Sites: Birmingham, Alabama; Anchorage, Alaska; Fayetteville, Arkansas · 70 sites in all
Centro Neurológico de Pesquisa e Reabiitação, BrazilAcademic, hospital or other
NCT03147092 · 15,000 participants (planned) · Start Feb 1, 2018 · Primary completion Jun 30, 2020
Drug: Captopril 25Mg, Hydrochlorothiazide 25Mg Oral Tablet,; Atenolol and 2 more · For: Hypertension; Blood Pressure
- Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic HypertensionPivotal-lookingTerminated
NovartisNovartis (NVS)
NCT00170950 · 11,506 participants · Start Oct 2003 · Primary completion Jan 2008
Drug: Benazepril/amlodipine 20/5 mg - Dose Level 1 from Day 1 to Month 1; Benazepril/amlodipine 40/5 mg - Dose Level 2 from Month 1 to Month 2 and 4 more · For: Hypertension
Sites: East Hanover, New Jersey; Denmark, Denmark; Finland, Finland · 5 sites in all
- Action to Control Cardiovascular Risk in Diabetes (ACCORD)Pivotal-lookingCompleted
National Heart, Lung, and Blood Institute (NHLBI)NIH
NCT00000620 · 10,251 participants · Start Sep 1999 · Primary completion Jun 2009
Drug: Anti-hyperglycemic Agents; Anti-hypertensive Agents and 1 more · For: Atherosclerosis; Cardiovascular Diseases; Hypercholesterolemia and 4 more
Sites: Minneapolis, Minnesota; New York, New York; Winston-Salem, North Carolina · 7 sites in all
- Recurrent Stroke Prevention Clinical Outcome StudyPivotal-lookingStatus unknown
Biomedis International Ltd.Academic, hospital or other
NCT01198496 · 5,000 participants (planned) · Start Oct 2010 · Primary completion Dec 2017
Drug: Losartan, Losartan and HCTZ, Amlodipine , Spironolactone · For: Hypertension; Stroke; Blood Pressure
Sites: Shimotsuke, Japan
- Rural Andhra Pradesh Cardiovascular Prevention Study (RAPCAPS)Pivotal-lookingCompleted
The George InstituteAcademic, hospital or other
NCT00263393 · 3,712 participants · Start Dec 2005 · Primary completion Dec 2008
Drug: ASA, Atenolol, hydrochlorothiazide, ACE inhibitor, Statin · For: Myocardial Infarction; Angina Pectoris; Cerebrovascular Accidents and 1 more
Sites: Bhimavaram, India
- Valsartan/Hydrochlorothiazide Combination in Hypertensive Patients Not Controlled With Valsartan AlonePivotal-lookingCompleted
NovartisNovartis (NVS)
NCT00170989 · 2,714 participants · Start Sep 2004 · Primary completion Jul 2005
Drug: valsartan plus hydrochlorothiazide · For: Hypertension
Sites: Investigative Centers, Germany; Basel, Switzerland
Most reported adverse reactions
FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.
- off label use88
- dyspnoea81
- pyrexia79
- diarrhoea73
- hypotension71
- drug ineffective66
- pneumonia63
- respiratory failure62
- pain59
- vomiting52
- death50
- cough48
FAERS reports by year
By the date FDA received the report.
View as table
| Year | Reports |
|---|---|
| 2004 | 19 |
| 2005 | 25 |
| 2006 | 19 |
| 2007 | 25 |
| 2008 | 16 |
| 2009 | 27 |
| 2010 | 35 |
| 2011 | 55 |
| 2012 | 40 |
| 2013 | 53 |
| 2014 | 56 |
| 2015 | 55 |
| 2016 | 84 |
| 2017 | 63 |
| 2018 | 120 |
| 2019 | 107 |
| 2020 | 108 |
| 2021 | 92 |
| 2022 | 93 |
| 2023 | 61 |
| 2024 | 43 |
| 2025 | 41 |
| 2026 | 26 |
Recalls
0 FDA enforcement reports for this application.
No recalls on record for this application.
Shortages
FDA's drug shortage list.
To Be Discontinued · updated Feb 10, 2026
Diuril, Oral Suspension, 250 mg/5mL (NDC 65649-311-12).
Medicare spending
CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.
Part D: Diuril (Chlorothiazide)
2024 spending
$21K
Beneficiaries
85
236 claims
Per beneficiary
$247
$0.31 per unit
View as table
| Year | Spending |
|---|---|
| 2020 | $20,134 |
| 2021 | $24,603 |
| 2022 | $30,867 |
| 2023 | $17,639 |
| 2024 | $20,999 |
Published evidence
PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.
- Diuretics use in the management of bronchopulmonary dysplasia in preterm infants: A systematic review.
Ó Briain E, Byrne AO, Dowling J, et al. · Acta Paediatr 2024 · Systematic Review
- Diuretic Strategies for Loop Diuretic Resistance in Acute Heart Failure: The 3T Trial.
Cox ZL, Hung R, Lenihan DJ, et al. · JACC Heart Fail 2020 · Randomized Controlled Trial, Research Support, N.I.H., Extramural
- A Systematic Review and Meta-Analysis of Metolazone Compared to Chlorothiazide for Treatment of Acute Decompensated Heart Failure.
Steuber TD, Janzen KM, Howard ML · Pharmacotherapy 2020 · Meta-Analysis, Systematic Review
- beta-Adrenoreceptor-blocking agents and lipid metabolism.
England JD, Hua AS, Shaw J · Clin Sci Mol Med Suppl 1978 · Clinical Trial, Randomized Controlled Trial
- Hypertension treated by sodium restriction.
Morgan TO, Myers JB · Med J Aust 1981 · Clinical Trial, Comparative Study
- Effects of chlorothiazide on urinary excretion of calcium in clinically normal dogs.
Lulich JP, Osborne CA · Am J Vet Res 1992 · Clinical Trial, Randomized Controlled Trial
Sponsor: Salix Pharms
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.